Molecular Data Accounts Payable

The latest accounts payable for MKD is $310M as of September 2021. Investors often review this figure alongside Molecular Data's historical trend and sector peers before judging valuation or financial health.

A accounts payable figure of $310M for MKD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MKD's accounts payable ($310M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Molecular Data's accounts payable against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.